U

United Laboratories International Holdings Ltd
HKEX:3933

Watchlist Manager
United Laboratories International Holdings Ltd
HKEX:3933
Watchlist
Price: 14.9 HKD 1.64%
Market Cap: 27.1B HKD

Wall Street
Price Targets

Price Targets Summary
United Laboratories International Holdings Ltd

Wall Street analysts forecast United Laboratories International Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for United Laboratories International Holdings Ltd is 16.13 HKD with a low forecast of 12.12 HKD and a high forecast of 19.95 HKD.

Lowest
Price Target
12.12 HKD
19% Downside
Average
Price Target
16.13 HKD
8% Upside
Highest
Price Target
19.95 HKD
34% Upside
United Laboratories International Holdings Ltd Competitors:
Price Targets
600267
Zhejiang Hisun Pharmaceutical Co Ltd
44% Downside
XERS
Xeris Biopharma Holdings Inc
27% Upside
AXSM
Axsome Therapeutics Inc
63% Upside
ZTS
Zoetis Inc
31% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
15% Upside
200670
Humedix Co Ltd
6% Upside
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
23% Upside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
6% Upside

Revenue
Forecast

Revenue Estimate
United Laboratories International Holdings Ltd

For the last 13 years the compound annual growth rate for United Laboratories International Holdings Ltd's revenue is 8%. The projected CAGR for the next 3 years is 5%.

8%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
United Laboratories International Holdings Ltd

For the last 13 years the compound annual growth rate for United Laboratories International Holdings Ltd's operating income is 20%. The projected CAGR for the next 3 years is 4%.

20%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
United Laboratories International Holdings Ltd

For the last 13 years the compound annual growth rate for United Laboratories International Holdings Ltd's net income is 30%. The projected CAGR for the next 3 years is 7%.

30%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is United Laboratories International Holdings Ltd's stock price target?
Price Target
16.13 HKD

According to Wall Street analysts, the average 1-year price target for United Laboratories International Holdings Ltd is 16.13 HKD with a low forecast of 12.12 HKD and a high forecast of 19.95 HKD.

What is United Laboratories International Holdings Ltd's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for United Laboratories International Holdings Ltd's revenue is 8%. The projected CAGR for the next 3 years is 5%.

What is United Laboratories International Holdings Ltd's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for United Laboratories International Holdings Ltd's operating income is 20%. The projected CAGR for the next 3 years is 4%.

What is United Laboratories International Holdings Ltd's Net Income forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for United Laboratories International Holdings Ltd's net income is 30%. The projected CAGR for the next 3 years is 7%.

Back to Top